EXACT Therapeutics AS
Clinical-stage biopharma using ultrasound to amplify the effect of co-administered drugs.
EXTX | OL
Overview
Corporate Details
- ISIN(s):
- NO0010852205 (+1 more)
- LEI:
- 2138006ZE5JAL39AGD55
- Country:
- Norway
- Address:
- Østre Aker vei 19, 0581 Oslo
- Website:
- https://www.exact-tx.com/
- Sector:
- Manufacturing
Description
EXACT Therapeutics AS is a clinical-stage biopharmaceutical company developing its proprietary technology platform, Acoustic Cluster Therapy (ACT®), for targeted therapeutic enhancement. The ACT® platform uses ultrasound to amplify the effect of co-administered drugs, with a primary focus on oncology. Its biomechanical mode of action increases the local uptake of therapeutics from blood vessels into the surrounding tissue, including across the blood-brain barrier, without requiring drug reformulation. This non-invasive technology is designed to be compatible with standard ultrasound systems. The company's pipeline includes the ENACT study, a Phase 2 trial evaluating ACT® in patients with locally advanced pancreatic cancer, following the completion of the ACTIVATE Phase 1 study in patients with liver metastases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-25 12:57 |
EXACT Therapeutics to present company update - Attachment: 251125 Exact Therap…
|
English | 1.5 MB | ||
| 2025-11-25 12:57 |
EXACT Therapeutics to present company update
|
English | 1.1 KB | ||
| 2025-11-24 08:25 |
EXACT Therapeutics AS: New option program and receipt of share options by prima…
|
English | 112.5 KB | ||
| 2025-11-24 08:25 |
EXACT Therapeutics AS: New option program and receipt of share options by prima…
|
English | 2.2 KB | ||
| 2025-09-25 08:00 |
EXACT Therapeutics first half 2025 interim results - Attachment: EXACT Therape…
|
English | 743.7 KB | ||
| 2025-09-25 08:00 |
EXACT Therapeutics first half 2025 interim results
|
English | 1.4 KB | ||
| 2025-09-18 08:00 |
EXACT Therapeutics’ Phase 2 trial to be presented at the 2025 AACR Special Conf…
|
English | 2.0 KB | ||
| 2025-09-09 08:00 |
EXACT Therapeutic’s Acoustic Cluster Therapy to be presented at the Ninth Inter…
|
English | 2.0 KB | ||
| 2025-08-12 08:30 |
EXACT Therapeutics to Present at the European Society for Medical Oncology (ESM…
|
English | 1.8 KB | ||
| 2025-08-11 11:08 |
Financial calendar
|
English | 430 bytes | ||
| 2025-07-08 08:30 |
EXACT Therapeutics announces grant of core patent in the U.S.
|
English | 1.9 KB | ||
| 2025-06-24 08:00 |
EXACT Therapeutics announces first patient dosed in Phase 2 trial in patients w…
|
English | 3.0 KB | ||
| 2025-06-13 12:09 |
EXACT Therapeutics AS: Primary insider notification - Attachment: Notification …
|
English | 41.4 KB | ||
| 2025-06-13 12:09 |
EXACT Therapeutics AS: Primary insider notification
|
English | 1.3 KB | ||
| 2025-06-13 12:05 |
EXACT Therapeutics minutes from Annual General Meeting June 13, 2025 - Attachme…
|
Norwegian | 729.7 KB |
Automate Your Workflow. Get a real-time feed of all EXACT Therapeutics AS filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for EXACT Therapeutics AS
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for EXACT Therapeutics AS via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
